Literature DB >> 2558583

Oxygen tolerance in neonatal rats: role of subcellular superoxide generation.

H Ischiropoulos1, C E Nadziejko, T Kumae, Y Kikkawa.   

Abstract

We compared the superoxide anion generating capacity of subcellular fractions from the lungs of neonatal and adult rats. Microsomal and mitochondrial fractions from adult rats produced approximately three times more superoxide (nanomoles per minute per milligram protein) than fractions from neonatal rats in the presence of 100% O2. Subcellular superoxide anion generating capacity was also examined in adult and neonatal rats exposed to greater than 95% fractional concentration of O2 in inspired gas. The O2- produced by mitochondrial and microsomal fractions of adult and neonatal rats increased above control levels for the first 24 h and declined below control values after 48 h of exposure in adults, whereas the elevated O2- production was sustained in microsomal fractions of neonates through 60 h. During the course of hyperoxic exposure, the largest difference in the superoxide generating capacity between adult and neonate was observed after 8-24 h of hyperoxia. The microsomal and mitochondrial fractions from adult rats produced three to seven times more O2- compared with neonatal rats. Cu,Zn superoxide dismutase (SOD) increased during the course of hyperoxia only in neonates at 8, 24, and 48 h of exposure. No change was observed in the activity of Mn SOD. The ratio of SOD activity (units per lung) to subcellular superoxide generating capacity (nanomoles per minute per lung) was calculated for the normal adults and neonates. The ratio for adult rats averaged 23 and 17 for mitochondrial and microsomal fractions, respectively, and 51 for neonatal rats for both subcellular fractions under normoxic conditions. These results suggest that O2- tolerance of neonates may be explained by the favorable balance between antioxidant defenses and subcellular superoxide generating capacity. The role of increased activity of Cu,Zn SOD as an accompanying or a causative phenomenon in O2 tolerance of neonates could not be determined from these experiments.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2558583     DOI: 10.1152/ajplung.1989.257.6.L411

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Development of a simultaneous multiple measurement method for superoxide generation from phagocytes using the cytochrome c reduction method.

Authors:  T Kumae
Journal:  Environ Health Prev Med       Date:  1996-07       Impact factor: 3.674

2.  Developmental differences in hyperoxia-induced oxidative stress and cellular responses in the murine lung.

Authors:  Sara K Berkelhamer; Gina A Kim; Josiah E Radder; Stephen Wedgwood; Lyubov Czech; Robin H Steinhorn; Paul T Schumacker
Journal:  Free Radic Biol Med       Date:  2013-03-14       Impact factor: 7.376

3.  Pertussis toxin treatment alters manganese superoxide dismutase activity in lung. Evidence for lung oxygen toxicity in air-breathing rats.

Authors:  L B Clerch; G Neithardt; U Spencer; J A Melendez; G D Massaro; D Massaro
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 4.  Developmental regulation of antioxidant enzymes and their impact on neonatal lung disease.

Authors:  Sara K Berkelhamer; Kathryn N Farrow
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

5.  Maturational differences in lung NF-kappaB activation and their role in tolerance to hyperoxia.

Authors:  Guang Yang; Aida Abate; Adia G George; Yi-Hao Weng; Phyllis A Dennery
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

6.  Expression level and subcellular localization of heme oxygenase-1 modulates its cytoprotective properties in response to lung injury: a mouse model.

Authors:  Fumihiko Namba; Hayato Go; Jennifer A Murphy; Ping La; Guang Yang; Shaon Sengupta; Amal P Fernando; Mekdes Yohannes; Chhanda Biswas; Suzanne L Wehrli; Phyllis A Dennery
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.